DOXGX | IPETX | DOXGX / IPETX | |
Total Expense Ratio | 0.41 | 1.09 | 38% |
Annual Report Gross Expense Ratio | 0.46 | 1.27 | 36% |
Fund Existence | 3 years | 12 years | - |
Gain YTD | 3.684 | 3.183 | 116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 531M | 21,469% |
Annual Yield % from dividends | 1.49 | 1.48 | 101% |
Returns for 1 year | 6.03 | 5.70 | 106% |
Returns for 3 years | 28.44 | -48.39 | -59% |
Returns for 5 years | N/A | -35.10 | - |
Returns for 10 years | N/A | -42.00 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MLNSX | 25.56 | N/A | N/A |
Morgan Stanley Instl Glbl Concntr R6 | |||
TQVIX | 17.59 | -0.20 | -1.12% |
T. Rowe Price Integrated US LCV Eq I | |||
GHTMX | 15.00 | -0.18 | -1.19% |
Goldman Sachs International T/M Eq Instl | |||
PAULX | 41.95 | -0.54 | -1.27% |
T. Rowe Price US Large-Cap Core Adv | |||
TADAX | 28.59 | -0.43 | -1.48% |
Transamerica US Growth A |